Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of Nemo-like Kinase Increases Taxol Sensitivity in Laryngeal Cancer

  • Dong, Ji-Rui (School of Life Science, Beijing Institute of Technology) ;
  • Guo, Nan (School of Life Science, Beijing Institute of Technology) ;
  • Zhao, Jian-Pu (School of Life Science, Beijing Institute of Technology) ;
  • Liu, Pin-Duo (School of Life Science, Beijing Institute of Technology) ;
  • Feng, Hui-Hong (School of Life Science, Beijing Institute of Technology) ;
  • Li, Yan (School of Life Science, Beijing Institute of Technology)
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Several studies have shown that nemo-like kinase (NLK) plays a vital role in apoptosis of cancer cells. The present research concerned effects and mechanisms of Taxol on NLK knockdown human laryngeal cancerHep-2 cell lines in vitro. Using RNAi, methyl-thiazoltetrazolium (MTT) assays, real-time RT-PCR, Western blotting and flow cytometry analysis, growth and the cell cycle progression of NLK knockdown Hep-2 cells and expression of downstream molecules were observed. Cell growth was obviously suppressed in the Taxol treated group (P<0.001, 48 hours). Cell numbers of combined Taxol-based chemotherapy with lentivirus mediated RNAi treatment group (Lv-shNLK+Taxol goup) were significantly different from NLK-specific siRNA lentivirus infected group (Lv-shNLK group) (p<0.001). Flow cytometry analysis revealed that Lv-shNLK+Taxol caused the G0/G1-phase DNA content to decrease from 44.1 to 3.33% (p<0.001) and the S-phase DNA content to increase from 38.4 to 82.0% (p<0.001), in comparison with the Lv-shNLK+Taxol group. Immunoblot analysis showed that knockdown of NLK led to significant reduction in the levels of cyclin D1, PCNA and PARP, whereas cyclin B1 was elevated in. Cell growth was also obviously suppressed in the Hep-2 cell line, knockdown of NLK making them more sensitive to Taxol treatment. NLK is expected to become a target of new laryngeal cancer gene therapies.

Keywords

References

  1. Brott BK, Pinsky BA, Erikson RL (1998). Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc Natl Acad Sci USA, 95, 963-8. https://doi.org/10.1073/pnas.95.3.963
  2. Cui G, Li Z, Shao B, et al (2011). Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci, 18, 271-5. https://doi.org/10.1016/j.jocn.2010.05.037
  3. Essers J, Theil AF, Baldeyron C, et al (2005). Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol, 25, 9350-59. https://doi.org/10.1128/MCB.25.21.9350-9359.2005
  4. Emami KH, Brown LG, Pitts TE, et al (2009). Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells. Prostate, 69, 1481-92. https://doi.org/10.1002/pros.20998
  5. Hershko A (1999). Mechanisms and regulation of the degradation of cyclin B. Philos Trans R Soc Lond B Biol Sci, 354, 1571-5. https://doi.org/10.1098/rstb.1999.0500
  6. Harada H, Yoshida S, Nobe Y, et al (2002). Genomic structure of the human NLK (nemo-like kinase) gene and analysis of its promoter region. Gene, 285, 175-82. https://doi.org/10.1016/S0378-1119(02)00412-2
  7. Ishitani T, Ninomiya-Tsuji J, Nagai S, et al (1999). The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature, 399, 798-802. https://doi.org/10.1038/21674
  8. Ito M (2000). Factors controlling cyclin B expression. Plant Mol Biol, 43, 677-90. https://doi.org/10.1023/A:1006336005587
  9. Jung KH, Kim JK, Noh JH, et al (2010). Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem, 110, 687-96. https://doi.org/10.1002/jcb.22579
  10. Kim M, Lee HC, Tsedensodnom O, et al (2008). Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol, 48, 780-91. https://doi.org/10.1016/j.jhep.2007.12.020
  11. Lazebnik YA, Kaufmann SH, Desnoyers S, et al (1994). Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-7, 1994. https://doi.org/10.1038/371346a0
  12. Lee JY, Marston DJ, Walston T (2006). Wnt/Frizzled signaling controls C. elegans gastrulation by activating actomyosin contractility. Curr Biol, 16, 1986-97. https://doi.org/10.1016/j.cub.2006.08.090
  13. Nicholson DW, Ali A, Thornberry NA, et al (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43. https://doi.org/10.1038/376037a0
  14. Nestle FO, Alijagic S, Gilliet M, et al (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4, 328-32. https://doi.org/10.1038/nm0398-328
  15. Satoh MS and Lindahl T (1992). Role of poly (ADP-ribose) formation in DNA repair. Nature, 356, 356-8. https://doi.org/10.1038/356356a0
  16. Shivji KK, Kenny MK and Wood RD (1992). Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 69, 367-74. https://doi.org/10.1016/0092-8674(92)90416-A
  17. Sanderson RJ and Ironside JA (2002). Squamous cell carcinomas of the head and neck. BMJ, 325, 822-7. https://doi.org/10.1136/bmj.325.7368.822
  18. Stevens KN, Kelemen LE, Wang X, et al (2012). Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 21, 523-8. https://doi.org/10.1158/1055-9965.EPI-11-0797
  19. Tewari M, Quan LT, O'Rourke K, et al (1995). Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell, 81, 801-9. https://doi.org/10.1016/0092-8674(95)90541-3
  20. Yasuda J, Tsuchiya A, Yamada T (2003). Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun, 308, 227-33. https://doi.org/10.1016/S0006-291X(03)01343-3
  21. Yuzugullu H, Benhaj K, Ozturk N, et al (2009). Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer, 8, 90. https://doi.org/10.1186/1476-4598-8-90
  22. Zhang Y, Peng C, Wu G, et al (2011). Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer, 21, 1380-7. https://doi.org/10.1097/IGC.0b013e3182262030
  23. Zhang X, Li W, Li H, et al (2012). Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. Anticancer Drugs, 23, 856-64. https://doi.org/10.1097/CAD.0b013e3283548d73

Cited by

  1. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine vol.13, pp.1, 2015, https://doi.org/10.1186/s12967-015-0533-x
  2. Study on the Correlation between Extracellular Matrix Protein-1 and the Growth, Metastasis and Angiogenesis of Laryngeal Carcinoma vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2313
  3. The emerging role of Nemo-like kinase (NLK) in the regulation of cancers vol.36, pp.12, 2015, https://doi.org/10.1007/s13277-015-4159-7
  4. An optical detection method for analyzing the cellular response to paclitaxel at the single cell level vol.8, pp.18, 2016, https://doi.org/10.1039/C6AY00017G
  5. Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-01480-2